Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH

PURPOSE: A proportion of patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) do not achieve treatment goals or experience side effects on their current therapy. In such cases, switching patients to a new drug while discontinuing the first may...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lung
Hlavní autoři: Gall, Henning, Vachiéry, Jean-Luc, Tanabe, Nobuhiro, Halank, Michael, Orozco-Levi, Mauricio, Mielniczuk, Lisa, Chang, MiKyung, Vogtländer, Kai, Grünig, Ekkehard
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2018
Témata:
Pulmonary Hypertension
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942346/
https://ncbi.nlm.nih.gov/pubmed/29470642
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00408-018-0100-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky